Overview
Base Editing of *HBG1* and *HBG2* Promoters for Sickle Cell Disease
May 7, 2026DOI: 10.1056/nejmoa2504835Original ArticleNEJM
Written by: Ashish O. Gupta, M.B., B.S., M.P.H.Akshay Sharma, M.B., B.S.Haydar Frangoul, M.D.Julie Kanter, M.D.Markus Y. Mapara, M.D., Ph.D.Jignesh Dalal, M.D.Asif Alavi, M.D.Jennifer J. Jaroscak, M.D.Ernesto Ayala, M.D.John F. DiPersio, M.D., Ph.D.Edward D. Ziga, M.D., M.P.H.Mary Eapen, M.B., B.S.Stacey Rifkin-Zenenberg, D.O.Alex C. Minella, M.D.Yinzhong Chen, Ph.D.Sarah Chesler, B.S.N., B.S.Srikanth Ambati, M.D.Thomas S. Bowman, M.D., M.P.H.Bahru Habtemariam, Pharm.D.Marcelyne Joseney-Antoine, B.Sc.Priya S. Chockalingam, Ph.D.Ling Lin, Ph.D.Sunita Goyal, M.D.Amy Simon, M.D.Alexis A. Thompson, M.D., M.P.H.Matthew M. Heeney, M.D.
Find these authors on Roon
JK

Classical Hematology · UAB

